An Approach to Studying Lung Cancer-related Proteins in Human Blood-Reference-Cited by-全球学者库

An Approach to Studying Lung Cancer-related Proteins in Human Blood

Published:2005-10 Issue:10 Volume:4 Page:1480-1486
ISSN:1535-9476
Container-title:Molecular & Cellular Proteomics
language:en
Short-container-title:Molecular & Cellular Proteomics

Author:

Xiao Ting,Ying Wantao,Li Lei,Hu Zhi,Ma Ying,Jiao Liyan,Ma Jinfang,Cai Yun,Lin Dongmei,Guo Suping,Han Naijun,Di Xuebing,Li Min,Zhang Dechao,Su Kai,Yuan Jinsong,Zheng Hongwei,Gao Meixia,He Jie,Shi Susheng,Li Wuju,Xu Ningzhi,Zhang Husheng,Liu Yan,Zhang Kaitai,Gao Yanning,Qian Xiaohong,Cheng Shujun

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Analytical Chemistry

Reference36 articles.

1. Protein profiles associated with survival in lung adenocarcinoma;Chen;Proc. Natl. Acad. Sci. U S A.,2003

2. Lung cancer;Hoffman;Lancet,2000

3. Tumor markers in lung cancer: EGTM recommendations;Stieber;Anticancer Res.,1999

4. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery;Celis;Mol. Cell. Proteomics,2004

5. Clinical proteomics: written in blood;Liotta;Nature,2003

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic biomarker discovery based on proteome landscape of Chinese lung adenocarcinoma;Clinical Proteomics;2024-01-05

2. Recent advancement in the detection of potential cancer biomarkers using the nanomaterial integrated electrochemical sensing technique: a detailed review;Materials Advances;2024

3. Exploring the macromolecules for secretory pathway in cancer disease;Secretory Proteins;2023

4. Determination of temporal reproducibility and variability of cancer biomarkers in serum and EDTA plasma samples using a proximity extension assay;Clinical Proteomics;2022-11-15

5. Differential plasma proteomes of the patients with Opisthorchiasis viverrini and cholangiocarcinoma identify a polymeric immunoglobulin receptor as a potential biomarker;Heliyon;2022-10